January 13, 2023/Cancer

Case Study: Main Duct Intraductal Papillary Mucinous Neoplasm Treated with Total Pancreatectomy and Chemotherapy

Pancreas and spleen removed to minimize risk of pancreatic cancer

pancreas

When a 58-year-old man notified his primary care provider that he was experiencing abdominal pain and was seeing what looked like oil in the toilet when he had a bowel movement, she ordered a CT scan. The patient was experiencing exocrine pancreatic insufficiency, resulting in oily stools due to fat malabsorption. The CT revealed a cyst on the pancreas and to further characterize it, his doctor referred him to gastroenterologist Amit Bhatt, MD, who followed up with an endoscopic ultrasound. This revealed main duct intraductal papillary mucinous neoplasm (IPMN), a benign pancreatic cyst. These cysts are a risk factor for developing into pancreatic cancer. While the diagnosis was frightening, when the disease is caught early, as in this case, it significantly improves the chances of a positive outcome.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Tumor board recommendations

In most instances, IPMN is not treated operatively. Instead, it is monitored closely with frequent imaging. A set of guidelines is used to determine if IPMNs are more likely to be good actors or bad actors, and for those bad actors, a distal pancreatectomy or a whipple procedure can be performed to remove the risky lesions. In this case, the patient’s cyst was discussed amongst a multidisciplinary team, involving the pancreatic surgeon Robert Simon, MD, oncologist Bahar Laderian, MD, and gastroenterologist Amit Bhatt, MD, and deemed to be more likely to be a bad actor. Therefore, the consensus was to have it removed. The unusual part of his case is that it involved the entire pancreas and therefore, a total pancreatectomy with a splenectomy was required in order to remove it.

Surgical course

The surgery itself took approximately six hours and went well. The patient’s recovery was uneventful. He was discharged from the hospital after about a week. The entire specimen was analyzed by the pathologists, and there was a small (0.5cm) focus of adenocarcinoma found in the pancreas. “It was caught early and had not metastasized to the lymph nodes,” says Dr. Simon.

Next steps

After the surgery, the patient’s case was brought back to the multidisciplinary team, and the recommendation was that in order to give the patient the best chance at survival, he should receive the triple-drug regimen FOLFIRINOX. As soon as the patient consented to the treatment, the Cleveland Clinic team, including pharmacists and infusion nurses, set to work behind the scenes to provide a swift time to treatment. This included preparing the patient to have a port placed to receive the chemotherapy and planning the infusion schedule.

Advertisement

A social worker was also assigned to help the patient with the emotional challenges of his long journey. “I think a social worker is really essential for complete cancer care,” says Dr. Laderian. “They are genuinely there to help everyone, the patient, their family and their care team.”

Managing the chemotherapy journey

The patient struggled with fatigue, nausea and vomiting through the chemotherapy treatment, and his medical team worked closely with him to keep tabs on his symptoms and prescribe medications to alleviate his symptoms. Ultimately, he completed ten cycles of FOLFIRINOX. After finishing chemotherapy, he receives periodic scans and blood tests to check for tumor markers.

Next steps

Since the patient is now living without a pancreas, he does need to control his blood sugar with insulin. After he recovered from surgery, he connected with an endocrinologist near his home in Tuscarawas to learn how to manage his diabetes. He was also prescribed specific enzymes that are important for digestion, as well as vaccines to protect against some bacterial infections, such as pneumonia, now that his spleen is gone.

Advertisement

Looking forward

More than a year and a half post-surgery, the patient is doing well and has no signs of recurrent cancer. He has returned to work part time, and enjoys numerous endeavors, such as playing the bass in a rock band.

“This case highlights the importance of patients listening to their bodies, noticing possible warning signs and connecting with their care team so symptoms can be investigated,” said Dr. Simon. He adds, “It is also imperative to go to a center that has specialists familiar with taking care of pancreatic diseases, such as cysts, as there are a lot of subtleties, and you want a care team who can help you make the right decision.”

Related Articles

Women's health physician
April 16, 2024/Cancer
Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

Fluorescent imaging during small bowel surgery
April 11, 2024/Cancer/Surgical Oncology
Fluorescence Imaging Augments Surgical Inspection and Palpation for Small Bowel Carcinoid Tumors

Study demonstrates superior visualization of occult primary lesions

microwave ablation of liver tumor
150-Watt, Single-Antenna Microwave Ablation System Demonstrates Safety and Efficacy

New device offers greater tumor control for malignant liver lesions

viral-induced cancer
April 3, 2024/Cancer
Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer

Dr. Mukherjee at Cleveland Clinic
April 1, 2024/Cancer/Blood Cancers
Many Patients with “Indolent” Systemic Mastocytosis Experience Rapid Decline and Lower Survival

First-ever U.S. population-level retrospective analysis reveals many patients with systemic mastocytosis need faster intervention

Cleveland Clinic physiatrist
March 22, 2024/Cancer/Innovations
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Ad